Fund queen Gülen left office and lost 50 billion yuan in two and a half years
"The family has money to spend, CEIBS Medical is looking for Gülen."
There have been many rumors about Gülen in fund circles.
Recently, Gülen has been in the spotlight again, after Gülen stepped down from two CEIBS funds at the end of September.
On September 28, CEIBS Fund announced that Zhou Weiwen stepped down as manager of CEIBS Insight's one-year holding period hybrid fund, which will be independently managed by Dai Yunfeng, who previously co-served as the fund manager.
On the same day, Gülen stepped down as the manager of CEIBS Research Select Hybrid and CEIBS Alpha Hybrid, which were managed by Lu Chunqing and Peng Wei, who were previously co-managers respectively.
As for the reasons for the adjustment, the announcement indicated that it was due to the company's arrangement.
CEIBS Research Select was established in March 2021 with an offering size of more than $4 billion, and as of the second quarter of 2023, CEIBS Research Select had a mixed size of $2,037 million, Gülen's tenure was 2 years and 188 days, and the return during his tenure was -33.74%.
CEIBS Alpha Hybrid was established in August 2020 and had a scale of more than RMB18 billion at the end of the second quarter of 2021, and RMB7.749 billion two years later, with Gülen's tenure of 3 years and 39 days, with a return of -31.83% during his tenure.
After stepping down from the two funds, Gülen currently has a management scale of 66.901 billion yuan, and its funds include CEIBS Healthcare Innovation Stocks, CEIBS Mingrui New Start Hybrid and CEIBS Healthcare Hybrid.
According to data, from 2021 to the first half of 2023, CEIBS Healthcare under Gülen suffered a loss of RMB35.2 billion, CEIBS Mingrui New Starter lost RMB880 million, CEIBS Healthcare Innovation lost RMB8.1 billion, CEIBS Alpha lost RMB5.17 billion, and CEIBS Research Select lost RMB1.05 billion. The total loss exceeded 50 billion.
During two and a half years, Gülen managed the fund and earned more than $3 billion in management fees.
After Gülen stepped down from the two CEIBS funds, some people said, "I have made money in recent years, and this wave of cutting has become rich and free." ”
According to public information, Gülen, bachelor's degree in engineering physics from Tsinghua University, and then obtained a master's degree and a doctorate degree in biomedical engineering from Northwestern University, and independently won the American Heart Association (AHA) scientific research fund and served as the fund leader.
He has served as a researcher of Guojin Securities Research Institute (2011.02-2012.09) and a researcher of Minsheng Bank of Canada Fund Management Co., Ltd. (2012.09-2014.09).
He joined CEIBS Fund in October 2014 and has worked his way from researcher to fund manager.
At the end of 2019, Gülen's scale under management was 7.135 billion yuan, a year-on-year period of 183.72%; At the end of 2020, the scale under management soared 5 times, reaching 44.191 billion yuan; in 2021, although many of its heavy stocks have retreated, the scale of its products under management exceeded 100 billion.
With the switch of market style in 2022, the overall correction of the pharmaceutical sector, Gülen's investment in the pharmaceutical sector continues to "step on the thunder", and the "goddess of medicine" has also turned into "Ge Lige".
It is worth mentioning that in April this year, it was rumored on the Internet that a female fund manager bought a luxury house in the fourth phase of Shanghai Cuihu, with a unit price of nearly 440,000 square meters and a total value of 170 million.
As soon as this news came out, it immediately triggered a lot of speculation, and everyone wanted to know who this mysterious person was.
Later, a blogger broke the news pointing to Gülen, who complained: "If I lose so much money buying her fund, she will use the money I lost to inflate the price of Shanghai Cuihu I want to buy so high!" I'm really going to be angry. ”
Author | Zhang Xiaolei